LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | AZD 5438 | 3.33 | uM | LJP6 | 2 | J02 | 72 | hr | 2543 | 1214 | 5438 | 0.2232 | -0.4907 |
| SK-BR-3 | AZD 5438 | 3.33 | uM | LJP6 | 3 | J02 | 72 | hr | 2543 | 1397 | 5557 | 0.2514 | -0.4122 |
| SK-BR-3 | AZD 5438 | 10 | uM | LJP6 | 1 | J01 | 72 | hr | 2543 | 694 | 5258 | 0.1320 | -0.7104 |
| SK-BR-3 | AZD 5438 | 10 | uM | LJP6 | 2 | J01 | 72 | hr | 2543 | 657 | 5438 | 0.1208 | -0.7091 |
| SK-BR-3 | AZD 5438 | 10 | uM | LJP6 | 3 | J01 | 72 | hr | 2543 | 850 | 5557 | 0.1530 | -0.6217 |
| SK-BR-3 | Pelitinib | 0.04 | uM | LJP5 | 1 | I18 | 72 | hr | 2543 | 4918 | 5734 | 0.8576 | 0.7545 |
| SK-BR-3 | Pelitinib | 0.04 | uM | LJP5 | 2 | I18 | 72 | hr | 2543 | 5017 | 5761 | 0.8708 | 0.7787 |
| SK-BR-3 | Pelitinib | 0.04 | uM | LJP5 | 3 | I18 | 72 | hr | 2543 | 5088 | 5760 | 0.8832 | 0.8001 |
| SK-BR-3 | Pelitinib | 0.12 | uM | LJP5 | 1 | I17 | 72 | hr | 2543 | 4303 | 5734 | 0.7504 | 0.5656 |
| SK-BR-3 | Pelitinib | 0.12 | uM | LJP5 | 2 | I17 | 72 | hr | 2543 | 4085 | 5761 | 0.7090 | 0.4943 |
| SK-BR-3 | Pelitinib | 0.12 | uM | LJP5 | 3 | I17 | 72 | hr | 2543 | 4330 | 5760 | 0.7516 | 0.5700 |
| SK-BR-3 | Pelitinib | 0.37 | uM | LJP5 | 1 | I16 | 72 | hr | 2543 | 1707 | 5734 | 0.2977 | -0.2882 |
| SK-BR-3 | Pelitinib | 0.37 | uM | LJP5 | 2 | I16 | 72 | hr | 2543 | 1610 | 5761 | 0.2794 | -0.3214 |
| SK-BR-3 | Pelitinib | 0.37 | uM | LJP5 | 3 | I16 | 72 | hr | 2543 | 1745 | 5760 | 0.3029 | -0.2734 |
| SK-BR-3 | Pelitinib | 1.11 | uM | LJP5 | 1 | I15 | 72 | hr | 2543 | 1583 | 5734 | 0.2761 | -0.3326 |
| SK-BR-3 | Pelitinib | 1.11 | uM | LJP5 | 2 | I15 | 72 | hr | 2543 | 1703 | 5761 | 0.2956 | -0.2883 |
| SK-BR-3 | Pelitinib | 1.11 | uM | LJP5 | 3 | I15 | 72 | hr | 2543 | 1806 | 5760 | 0.3135 | -0.2520 |
| SK-BR-3 | Pelitinib | 3.33 | uM | LJP5 | 1 | I14 | 72 | hr | 2543 | 1759 | 5734 | 0.3067 | -0.2698 |
| SK-BR-3 | Pelitinib | 3.33 | uM | LJP5 | 2 | I14 | 72 | hr | 2543 | 1924 | 5761 | 0.3339 | -0.2107 |
| SK-BR-3 | Pelitinib | 3.33 | uM | LJP5 | 3 | I14 | 72 | hr | 2543 | 1914 | 5760 | 0.3322 | -0.2142 |
| SK-BR-3 | Pelitinib | 10 | uM | LJP5 | 1 | I13 | 72 | hr | 2543 | 1538 | 5734 | 0.2682 | -0.3488 |
| SK-BR-3 | Pelitinib | 10 | uM | LJP5 | 2 | I13 | 72 | hr | 2543 | 1609 | 5761 | 0.2793 | -0.3217 |
| SK-BR-3 | Pelitinib | 10 | uM | LJP5 | 3 | I13 | 72 | hr | 2543 | 1587 | 5760 | 0.2755 | -0.3296 |
| SK-BR-3 | Luminespib | 0.04 | uM | LJP5 | 1 | H18 | 72 | hr | 2543 | 1966 | 5734 | 0.3428 | -0.1971 |
| SK-BR-3 | Luminespib | 0.04 | uM | LJP5 | 2 | H18 | 72 | hr | 2543 | 2198 | 5761 | 0.3815 | -0.1164 |